1-3 of 3
Ginger Gillette-Kent, C.N.P
Close
Sort by
Journal Articles

Allogeneic Stem Cell Transplantation (allo-SCT) for Acute Myeloid Leukemia (AML): Low Incidence of Relapse and Graft Versus Host Disease (GVHD) in Patients (pts) Transplanted without Active Leukemia Using in-Vivo T-Cell Depletion with Rabbit Anti-Thymocyte Globulin (r-ATG)

James L. Slack, MD, Jose F. Leis, MD, PhD, Craig B. Reeder, MD, Joseph R. Mikhael, MD, Raoul Tibes, MD, PhD, Pierre Noel, MD, Ruben A. Mesa, MD, Jeffrey A. Betcher, R.Ph, Mary E Peterson, C.N.P, Meagan S. Higgins, C.N.P, Ginger Gillette-Kent, C.N.P, Lisa D. Tremblay, N.P, Jane J Olsen, N.P, Roberta H. Adams, MD
Journal: Blood
Blood (2011) 118 (21): 4527.
https://doi.org/10.1182/blood.V118.21.4527.4527
Published: 2011
Journal Articles

In-Vivo T-Cell Depletion with Rabbit Anti-Thymocyte Globulin (r-ATG) Prevents Severe Acute and Chronic Graft Versus Host Disease (GVHD) and Allows Safe Allogeneic Stem Cell Transplantation (allo-SCT) From Mismatched, Unrelated Donors

James L. Slack, MD, Jose F. Leis, MD, PhD, Craig B. Reeder, MD, Joseph R. Mikhael, MD, Pierre Noel, MD, Ruben A. Mesa, MD, Raoul Tibes, MD, PhD, Jeffrey A. Betcher, R.Ph, Mary E Peterson, C.N.P, Meagan S. Higgins, C.N.P, Ginger Gillette-Kent, C.N.P, Lisa D. Tremblay, N.P, Jane J. Olson, NP, Roberta H. Adams, MD
Journal: Blood
Blood (2011) 118 (21): 1977.
https://doi.org/10.1182/blood.V118.21.1977.1977
Published: 2011
Journal Articles

Induction Therapy Followed by Allogeneic Stem Cell Transplant for MPN Blast Phase: Outcomes From Mayo Clinic in Arizona

Chad Cherington, MD, James L. Slack, MD, Jose F. Leis, MD, PhD, Roberta H. Adams, MD, Craig B. Reeder, MD, Joseph R. Mikhael, MD, John Camoriano, MD, Pierre Noel, MD, Raoul Tibes, MD, PhD, Jeffrey A. Betcher, R.Ph, Mary E Peterson, C.N.P, Meagan S. Higgins, C.N.P, Ginger Gillette-Kent, C.N.P, Lisa D. Tremblay, N.P, Jane J Olsen, N.P, Ruben A. Mesa, MD
Journal: Blood
Blood (2011) 118 (21): 1749.
https://doi.org/10.1182/blood.V118.21.1749.1749
Published: 2011